Buprenorphine, also colloquially referred to as bupe, is an opioid drug with partial agonist and antagonist actions. Buprenorphine hydrochloride was first marketed in the 1980s by Reckitt & Colman (now Reckitt Benckiser) as an analgesic, yet is now primarily used for the treatment of opioid addiction. It is a Schedule III drug under the Convention on Psychotropic Substances*.
Buprenorphine is also delivered transdermally in 25, 50 and 75 mcg/hour. The trade name in the UK is Transtec, and manufactured by Napp. A new 5, 10 and 20 mcg/hour patch marketed as Bu'7rans (Bu-trans), where the 7 indicates its once weekly dosage for pain in osteoarthritis.
More on [ Buprenorphine ]

MedlinePlus: Buprenorphine Sublingual and Buprenorphine and Naloxone Sublingual - Provides information on usage, precautions, side effects and brand names when available. Data provided by government agencies and health-related organizations.
Meta Description: [ Buprenorphine Sublingual and Buprenorphine and Naloxone Sublingual ]
Suboxone / Subutex - Information for healthcare professionals and patients.
Meta Description: [ Information about SUBOXONE, an office based treatment for opioid dependence. ]
| KNVT Interview of Richard Gracer, MD 8/21/07 | |
| Next Video | |